| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
74,761 |
69,328 |
$19.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,536 |
43,545 |
$13.01M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,940 |
20,821 |
$7.20M |
| G0378 |
Hospital observation service, per hour |
11,292 |
5,340 |
$4.16M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,174 |
7,385 |
$4.05M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
6,993 |
2,899 |
$3.66M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
18,895 |
18,089 |
$3.34M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
11,100 |
10,150 |
$2.79M |
| OP710 |
|
21,624 |
16,378 |
$2.50M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26,748 |
20,243 |
$2.41M |
| J9271 |
Injection, pembrolizumab, 1 mg |
297 |
202 |
$2.18M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
14,031 |
13,110 |
$2.05M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
70,598 |
19,347 |
$2.05M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,321 |
19,523 |
$1.89M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,159 |
2,046 |
$1.86M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,908 |
11,486 |
$1.72M |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
2,169 |
1,454 |
$1.65M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,002 |
5,412 |
$1.59M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
44,521 |
13,358 |
$1.54M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,583 |
1,398 |
$1.36M |
| 70450 |
Computed tomography, head or brain; without contrast material |
11,358 |
10,019 |
$1.26M |
| 93017 |
|
4,262 |
3,776 |
$1.03M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
33,790 |
29,316 |
$1.01M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
29,377 |
25,887 |
$983K |
| OP270 |
|
31,720 |
20,557 |
$974K |
| OP250 |
|
212,587 |
98,515 |
$930K |
| OP272 |
|
25,609 |
17,423 |
$875K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,823 |
1,682 |
$850K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,195 |
3,833 |
$808K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14,020 |
12,704 |
$783K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,797 |
5,638 |
$757K |
| 71046 |
Radiologic examination, chest; 2 views |
19,981 |
18,786 |
$714K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
165 |
116 |
$691K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,714 |
7,535 |
$669K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,898 |
2,643 |
$655K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,476 |
8,671 |
$651K |
| 62323 |
|
709 |
639 |
$649K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,309 |
1,996 |
$634K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,928 |
7,440 |
$633K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,867 |
5,576 |
$625K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,893 |
2,873 |
$612K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
382 |
321 |
$585K |
| 94060 |
|
2,457 |
2,322 |
$569K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
364 |
232 |
$568K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
795 |
695 |
$546K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
72,001 |
58,830 |
$544K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,237 |
5,590 |
$530K |
| 76830 |
Ultrasound, transvaginal |
4,365 |
4,193 |
$525K |
| 90834 |
Psychotherapy, 45 minutes with patient |
13,852 |
4,907 |
$522K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,584 |
2,241 |
$489K |
| OP370 |
|
3,377 |
2,692 |
$469K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,479 |
16,228 |
$459K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
978 |
878 |
$446K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,296 |
4,054 |
$439K |
| 80053 |
Comprehensive metabolic panel |
43,382 |
34,716 |
$438K |
| 71045 |
Radiologic examination, chest; single view |
14,549 |
12,972 |
$425K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,928 |
1,733 |
$417K |
| 96415 |
|
2,287 |
1,541 |
$416K |
| 97161 |
|
7,391 |
6,614 |
$414K |
| 93970 |
|
2,232 |
2,002 |
$399K |
| 96376 |
|
6,164 |
3,913 |
$390K |
| J1756 |
Injection, iron sucrose, 1 mg |
6,075 |
2,691 |
$387K |
| 96417 |
|
1,784 |
1,015 |
$379K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,904 |
2,263 |
$373K |
| OP278 |
|
940 |
769 |
$359K |
| 71250 |
|
1,988 |
1,729 |
$325K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,508 |
3,577 |
$312K |
| 76536 |
|
2,762 |
2,603 |
$301K |
| J0897 |
Injection, denosumab, 1 mg |
225 |
199 |
$299K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
660 |
583 |
$295K |
| 76641 |
|
2,406 |
1,824 |
$281K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,085 |
1,050 |
$279K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
340 |
300 |
$273K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,828 |
3,751 |
$266K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,783 |
3,493 |
$260K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,288 |
5,131 |
$258K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,545 |
3,008 |
$254K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,842 |
2,436 |
$252K |
| 76801 |
|
3,535 |
3,264 |
$235K |
| 97162 |
|
3,377 |
3,104 |
$217K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
197 |
162 |
$216K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
132 |
117 |
$212K |
| 92557 |
|
2,033 |
1,842 |
$207K |
| 76642 |
|
2,376 |
2,142 |
$206K |
| 93971 |
|
1,945 |
1,756 |
$202K |
| 70486 |
|
1,209 |
1,104 |
$187K |
| 96367 |
|
3,201 |
2,195 |
$183K |
| 74183 |
|
249 |
224 |
$177K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,925 |
6,208 |
$173K |
| 00731 |
|
944 |
890 |
$166K |
| 77065 |
Tomosynthesis, mammo |
1,541 |
1,434 |
$159K |
| 76770 |
|
1,272 |
1,189 |
$158K |
| 73630 |
|
4,408 |
4,055 |
$157K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,524 |
1,086 |
$157K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
7,992 |
7,265 |
$152K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
143 |
102 |
$149K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,444 |
3,914 |
$148K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,316 |
4,884 |
$147K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,642 |
8,324 |
$146K |
| 77066 |
Tomosynthesis, mammo |
961 |
923 |
$145K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
261 |
232 |
$142K |
| 77080 |
|
1,612 |
1,556 |
$141K |
| C1776 |
Joint device (implantable) |
117 |
83 |
$140K |
| 94726 |
|
1,154 |
1,048 |
$135K |
| 80047 |
|
26,899 |
24,170 |
$132K |
| C9399 |
Unclassified drugs or biologicals |
1,890 |
1,747 |
$128K |
| 72197 |
|
166 |
151 |
$125K |
| 00811 |
|
625 |
564 |
$120K |
| 73560 |
|
3,794 |
3,357 |
$120K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,117 |
1,077 |
$120K |
| 84484 |
|
18,281 |
15,216 |
$119K |
| 36415 |
Collection of venous blood by venipuncture |
74,003 |
62,585 |
$117K |
| 92588 |
|
1,076 |
1,026 |
$113K |
| 20610 |
|
173 |
132 |
$113K |
| 93325 |
|
458 |
432 |
$113K |
| 73030 |
|
3,642 |
3,303 |
$112K |
| 73610 |
|
3,859 |
3,561 |
$111K |
| 99215 |
Prolong outpt/office vis |
1,241 |
1,060 |
$110K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,283 |
2,178 |
$109K |
| 76813 |
|
1,006 |
973 |
$109K |
| 81025 |
|
36,763 |
33,986 |
$108K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,116 |
1,071 |
$108K |
| 90791 |
Psychiatric diagnostic evaluation |
2,603 |
1,599 |
$106K |
| 86850 |
|
9,573 |
8,218 |
$104K |
| 47562 |
|
70 |
65 |
$95K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,291 |
1,247 |
$94K |
| 72100 |
|
2,665 |
2,509 |
$93K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
289 |
246 |
$91K |
| 87631 |
|
1,428 |
1,420 |
$90K |
| 12001 |
|
1,002 |
965 |
$86K |
| 93976 |
|
488 |
465 |
$85K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,036 |
1,875 |
$83K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,619 |
1,073 |
$82K |
| 86900 |
|
10,515 |
8,689 |
$81K |
| 94010 |
|
618 |
569 |
$81K |
| 73110 |
|
2,289 |
2,140 |
$80K |
| 74018 |
|
2,333 |
2,188 |
$80K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,282 |
1,135 |
$77K |
| 73130 |
|
2,717 |
2,485 |
$77K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,370 |
3,318 |
$76K |
| 86901 |
|
10,555 |
8,692 |
$76K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,991 |
3,856 |
$75K |
| OP258 |
|
41,439 |
22,548 |
$72K |
| 00840 |
|
275 |
245 |
$71K |
| 83880 |
|
5,024 |
4,305 |
$71K |
| 73502 |
|
1,789 |
1,597 |
$71K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
765 |
583 |
$70K |
| 96416 |
|
344 |
190 |
$70K |
| 59426 |
|
1,602 |
847 |
$68K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,024 |
7,645 |
$66K |
| 72131 |
|
669 |
565 |
$66K |
| 96401 |
|
838 |
576 |
$66K |
| 96411 |
|
239 |
151 |
$65K |
| 88304 |
|
2,136 |
1,993 |
$64K |
| 87486 |
|
2,894 |
2,874 |
$63K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,300 |
1,287 |
$63K |
| 88341 |
|
528 |
432 |
$62K |
| 70491 |
|
282 |
251 |
$62K |
| 87428 |
|
3,840 |
3,586 |
$60K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,989 |
3,854 |
$58K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,229 |
4,678 |
$57K |
| 87581 |
|
2,892 |
2,872 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,867 |
7,770 |
$55K |
| 94729 |
|
1,178 |
1,075 |
$55K |
| 93320 |
|
200 |
186 |
$55K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,028 |
939 |
$55K |
| 00813 |
|
210 |
195 |
$55K |
| 84702 |
|
5,603 |
4,754 |
$53K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,407 |
6,341 |
$51K |
| 10060 |
|
591 |
554 |
$51K |
| 97802 |
|
616 |
587 |
$49K |
| 97165 |
|
1,340 |
1,110 |
$49K |
| J2704 |
Injection, propofol, 10 mg |
11,560 |
10,597 |
$47K |
| 12011 |
|
601 |
574 |
$47K |
| 90715 |
|
2,481 |
2,328 |
$46K |
| 96523 |
|
766 |
497 |
$46K |
| 72110 |
|
620 |
583 |
$45K |
| 81001 |
|
15,712 |
14,274 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,482 |
1,698 |
$45K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,039 |
1,031 |
$43K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
695 |
530 |
$43K |
| 59425 |
|
1,087 |
763 |
$43K |
| 76857 |
|
678 |
675 |
$43K |
| 99241 |
|
796 |
616 |
$43K |
| 92567 |
|
1,084 |
972 |
$43K |
| 73700 |
|
327 |
259 |
$42K |
| 74021 |
|
1,140 |
1,107 |
$40K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,488 |
2,449 |
$40K |
| 93225 |
|
214 |
208 |
$40K |
| 83690 |
|
12,675 |
11,349 |
$40K |
| 93226 |
|
187 |
181 |
$40K |
| 76870 |
|
486 |
463 |
$40K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,084 |
8,481 |
$39K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,312 |
1,890 |
$38K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,191 |
1,151 |
$38K |
| 72141 |
|
92 |
80 |
$38K |
| 72040 |
|
1,170 |
1,099 |
$38K |
| 85610 |
|
11,486 |
10,015 |
$38K |
| 00812 |
|
148 |
131 |
$37K |
| 82962 |
|
12,830 |
8,785 |
$36K |
| 29125 |
|
958 |
906 |
$36K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
110 |
100 |
$36K |
| 19083 |
|
26 |
25 |
$35K |
| 87040 |
|
3,571 |
3,208 |
$35K |
| 83605 |
|
4,685 |
4,053 |
$35K |
| 83735 |
|
9,491 |
7,381 |
$34K |
| 85730 |
|
9,979 |
8,799 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,328 |
1,289 |
$33K |
| 64447 |
|
90 |
69 |
$33K |
| 73120 |
|
576 |
543 |
$33K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
384 |
249 |
$33K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
21,836 |
18,901 |
$32K |
| 71271 |
|
210 |
205 |
$32K |
| J1453 |
Injection, fosaprepitant, 1 mg |
874 |
547 |
$31K |
| 77336 |
|
286 |
120 |
$31K |
| 70496 |
|
192 |
155 |
$29K |
| 85027 |
|
6,245 |
4,653 |
$29K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
109 |
102 |
$29K |
| 0002A |
|
870 |
866 |
$28K |
| 92550 |
|
1,302 |
1,204 |
$28K |
| 11045 |
|
206 |
102 |
$28K |
| 81003 |
|
11,964 |
11,329 |
$27K |
| C1769 |
Guide wire |
1,004 |
789 |
$27K |
| 97113 |
|
584 |
174 |
$26K |
| 88342 |
|
995 |
836 |
$26K |
| 36430 |
|
457 |
311 |
$25K |
| 73140 |
|
878 |
844 |
$25K |
| 73562 |
|
809 |
699 |
$25K |
| 84145 |
|
1,967 |
1,664 |
$25K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
3,103 |
2,769 |
$25K |
| 73590 |
|
845 |
753 |
$23K |
| 87507 |
|
178 |
159 |
$23K |
| 0001A |
|
768 |
767 |
$23K |
| 80076 |
|
5,220 |
4,704 |
$23K |
| 81002 |
|
20,190 |
18,518 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
125 |
125 |
$22K |
| 77334 |
|
38 |
26 |
$22K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
47 |
40 |
$21K |
| 87186 |
|
3,159 |
2,927 |
$21K |
| 99242 |
|
582 |
393 |
$21K |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
39 |
28 |
$21K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
413 |
54 |
$20K |
| OP251 |
|
1,353 |
738 |
$19K |
| 73080 |
|
702 |
632 |
$19K |
| 87077 |
|
3,555 |
3,299 |
$19K |
| 72070 |
|
495 |
458 |
$19K |
| 77011 |
|
89 |
75 |
$19K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
777 |
128 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,418 |
4,403 |
$17K |
| 99152 |
|
426 |
389 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14,115 |
11,426 |
$17K |
| 96368 |
|
405 |
243 |
$17K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,131 |
1,091 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
398 |
396 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,752 |
3,133 |
$15K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,990 |
1,635 |
$15K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
547 |
215 |
$15K |
| 88307 |
|
244 |
207 |
$15K |
| 59025 |
Fetal non-stress test |
130 |
124 |
$14K |
| J9190 |
Injection, fluorouracil, 500 mg |
865 |
322 |
$14K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,074 |
4,617 |
$14K |
| J7050 |
Infusion, normal saline solution, 250 cc |
7,326 |
4,207 |
$14K |
| 11043 |
|
61 |
27 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,699 |
16,553 |
$14K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
25 |
25 |
$13K |
| 84100 |
|
4,254 |
3,262 |
$13K |
| 85378 |
|
3,229 |
3,024 |
$13K |
| 97164 |
|
266 |
244 |
$12K |
| 73090 |
|
426 |
394 |
$12K |
| 76818 |
|
126 |
63 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,137 |
12,758 |
$12K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,391 |
1,126 |
$12K |
| 80061 |
Lipid panel |
1,769 |
1,570 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,162 |
2,763 |
$11K |
| 92579 |
|
78 |
76 |
$11K |
| 0004A |
|
229 |
229 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
619 |
599 |
$10K |
| 92523 |
|
104 |
96 |
$10K |
| 73564 |
|
351 |
303 |
$10K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,548 |
3,387 |
$9K |
| 86140 |
|
3,683 |
3,251 |
$9K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
107 |
92 |
$9K |
| 77049 |
|
13 |
13 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,933 |
9,322 |
$8K |
| 00160 |
|
24 |
24 |
$8K |
| 70498 |
|
50 |
44 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
232 |
204 |
$8K |
| 10005 |
|
56 |
50 |
$8K |
| 77002 |
|
144 |
102 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
411 |
386 |
$8K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,238 |
1,146 |
$8K |
| A4648 |
Tissue marker, implantable, any type, each |
127 |
116 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,630 |
1,417 |
$8K |
| 82728 |
|
1,156 |
961 |
$7K |
| 72050 |
|
100 |
92 |
$7K |
| 29130 |
|
225 |
219 |
$7K |
| 97803 |
|
166 |
153 |
$7K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
259 |
197 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
204 |
181 |
$7K |
| 00402 |
|
15 |
12 |
$7K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
302 |
144 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
135 |
129 |
$7K |
| 82550 |
|
1,611 |
1,423 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,280 |
7,683 |
$6K |
| 95886 |
|
73 |
67 |
$6K |
| 90674 |
|
357 |
351 |
$6K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
147 |
84 |
$6K |
| 36591 |
|
106 |
76 |
$6K |
| 87420 |
|
1,273 |
1,187 |
$6K |
| 84466 |
|
1,031 |
855 |
$6K |
| 73620 |
|
156 |
145 |
$6K |
| 82077 |
|
1,059 |
917 |
$6K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
29,694 |
21,862 |
$6K |
| 0071A |
|
124 |
124 |
$6K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
201 |
129 |
$5K |
| 87070 |
|
844 |
779 |
$5K |
| 95800 |
|
62 |
62 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,295 |
4,657 |
$5K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,639 |
1,428 |
$5K |
| 80143 |
|
859 |
746 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
204 |
197 |
$5K |
| 0072A |
|
114 |
114 |
$5K |
| 90714 |
|
361 |
361 |
$5K |
| OP255 |
|
1,942 |
1,589 |
$5K |
| 90686 |
|
2,259 |
2,249 |
$5K |
| 85652 |
|
2,307 |
2,006 |
$5K |
| 97014 |
|
787 |
323 |
$5K |
| 90670 |
|
982 |
967 |
$5K |
| 80179 |
|
808 |
704 |
$5K |
| 99153 |
Mod sedat endo service >5yrs |
84 |
76 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
546 |
528 |
$5K |
| 00790 |
|
15 |
13 |
$5K |
| 00920 |
|
12 |
12 |
$5K |
| 71101 |
|
142 |
126 |
$5K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
534 |
382 |
$5K |
| 93880 |
|
35 |
27 |
$4K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,999 |
1,639 |
$4K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,165 |
4,837 |
$4K |
| 90474 |
|
598 |
597 |
$4K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,103 |
1,733 |
$4K |
| 73070 |
|
97 |
93 |
$4K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
680 |
371 |
$4K |
| 77300 |
|
15 |
13 |
$4K |
| 97535 |
Self-care/home management training, each 15 minutes |
451 |
309 |
$4K |
| 87641 |
|
524 |
397 |
$4K |
| 80320 |
|
75 |
60 |
$4K |
| 64415 |
|
15 |
12 |
$3K |
| 82607 |
|
587 |
480 |
$3K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,566 |
2,875 |
$3K |
| J3490 |
Unclassified drugs |
26,963 |
15,856 |
$3K |
| OP279 |
|
644 |
542 |
$3K |
| 84439 |
|
682 |
577 |
$3K |
| 97035 |
|
292 |
93 |
$3K |
| 0064A |
|
72 |
71 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,740 |
3,434 |
$3K |
| 88173 |
|
191 |
157 |
$3K |
| 59430 |
|
114 |
97 |
$3K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
909 |
610 |
$3K |
| 82150 |
|
563 |
533 |
$3K |
| 0011A |
|
80 |
80 |
$3K |
| 76820 |
|
48 |
25 |
$2K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,017 |
680 |
$2K |
| 0012A |
|
71 |
71 |
$2K |
| 87205 |
|
851 |
766 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
395 |
375 |
$2K |
| 87640 |
|
422 |
309 |
$2K |
| 82746 |
|
436 |
351 |
$2K |
| 29515 |
|
67 |
63 |
$2K |
| 74022 |
|
46 |
46 |
$2K |
| 85046 |
|
388 |
225 |
$2K |
| 82803 |
|
174 |
153 |
$2K |
| 72170 |
|
58 |
51 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
123 |
120 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
253 |
211 |
$2K |
| 83540 |
|
1,033 |
856 |
$2K |
| 86923 |
|
158 |
122 |
$2K |
| 83615 |
|
537 |
422 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
586 |
462 |
$2K |
| 85055 |
|
125 |
107 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
1,539 |
1,156 |
$1K |
| 82378 |
|
86 |
51 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,926 |
2,593 |
$1K |
| 87430 |
|
259 |
245 |
$1K |
| 0054A |
|
32 |
31 |
$1K |
| 92587 |
|
12 |
12 |
$1K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
445 |
362 |
$1K |
| 73060 |
|
50 |
43 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
2,404 |
1,037 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
594 |
355 |
$1K |
| 99156 |
|
15 |
14 |
$1K |
| 76000 |
|
15 |
15 |
$995.08 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
126 |
79 |
$948.92 |
| 76821 |
|
17 |
12 |
$936.27 |
| C9113 |
Injection, pantoprazole sodium, per vial |
803 |
477 |
$926.79 |
| 86308 |
|
268 |
250 |
$914.36 |
| 84156 |
|
226 |
189 |
$896.43 |
| 88300 |
|
91 |
89 |
$883.96 |
| 86592 |
|
428 |
408 |
$882.80 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
77 |
55 |
$793.40 |
| 86803 |
|
86 |
76 |
$761.39 |
| 82565 |
|
499 |
449 |
$745.84 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
353 |
260 |
$698.36 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
63 |
44 |
$629.13 |
| 82553 |
|
88 |
86 |
$624.77 |
| OP259 |
|
87 |
41 |
$620.60 |
| 0003A |
|
20 |
20 |
$614.80 |
| 73552 |
|
18 |
17 |
$610.67 |
| 90661 |
|
109 |
109 |
$579.72 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
90 |
89 |
$556.12 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
182 |
173 |
$549.04 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
188 |
176 |
$549.04 |
| 00902 |
|
14 |
13 |
$518.06 |
| 87076 |
|
104 |
104 |
$504.16 |
| 87075 |
|
67 |
57 |
$495.91 |
| 99381 |
|
12 |
12 |
$478.14 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
285 |
229 |
$468.07 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
28 |
19 |
$438.62 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
322 |
275 |
$438.00 |
| 82272 |
|
90 |
80 |
$432.57 |
| 94760 |
|
15 |
15 |
$423.43 |
| J1630 |
Injection, haloperidol, up to 5 mg |
453 |
359 |
$417.57 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
285 |
264 |
$390.81 |
| 82570 |
|
244 |
206 |
$383.62 |
| 90682 |
|
13 |
12 |
$381.72 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
37 |
12 |
$376.54 |
| 97750 |
|
47 |
42 |
$365.59 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
63 |
60 |
$365.57 |
| 90677 |
|
267 |
262 |
$315.94 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
96 |
92 |
$308.34 |
| 87081 |
|
62 |
60 |
$295.74 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
149 |
124 |
$292.56 |
| 73600 |
|
14 |
12 |
$281.27 |
| 90651 |
|
12 |
12 |
$280.61 |
| 90680 |
|
247 |
247 |
$276.08 |
| 96377 |
|
14 |
12 |
$274.75 |
| 97116 |
|
19 |
12 |
$242.96 |
| 75571 |
|
103 |
91 |
$238.50 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
114 |
91 |
$238.31 |
| J7510 |
Prednisolone oral, per 5 mg |
574 |
547 |
$227.70 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
414 |
363 |
$222.99 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
14 |
14 |
$212.55 |
| 87340 |
|
29 |
28 |
$203.92 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
550 |
483 |
$195.89 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
251 |
235 |
$186.98 |
| 87593 |
|
14 |
14 |
$185.57 |
| 90698 |
|
251 |
250 |
$164.85 |
| C7901 |
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
23 |
14 |
$162.50 |
| 86701 |
|
13 |
13 |
$160.20 |
| 0124A |
|
15 |
13 |
$142.20 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
49 |
49 |
$127.72 |
| J1836 |
Injection, metronidazole, 10 mg |
162 |
102 |
$126.38 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
104 |
62 |
$126.05 |
| 90633 |
|
135 |
128 |
$122.03 |
| 86780 |
|
13 |
12 |
$111.20 |
| 84703 |
|
16 |
16 |
$98.34 |
| 84132 |
|
29 |
26 |
$83.03 |
| C7900 |
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
18 |
12 |
$82.02 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
94 |
64 |
$75.10 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
43 |
38 |
$68.98 |
| 86480 |
|
15 |
12 |
$56.83 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
49 |
42 |
$47.15 |
| 84295 |
|
12 |
12 |
$45.51 |
| 86762 |
|
16 |
14 |
$41.20 |
| 90647 |
|
126 |
124 |
$39.00 |
| 86880 |
|
14 |
12 |
$38.53 |
| 85014 |
|
15 |
12 |
$25.61 |
| 85018 |
|
15 |
12 |
$24.62 |
| 90723 |
|
42 |
42 |
$22.08 |
| 90671 |
|
65 |
64 |
$22.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
14 |
12 |
$19.90 |
| 90648 |
|
13 |
13 |
$14.31 |
| 90681 |
|
284 |
283 |
$14.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
16 |
14 |
$12.36 |
| 90632 |
|
13 |
13 |
$7.00 |
| 90716 |
|
17 |
16 |
$6.00 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
193 |
162 |
$5.22 |
| J2305 |
Injection, nitroglycerin, 5 mg |
16 |
12 |
$3.10 |
| 90744 |
|
12 |
12 |
$3.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
17 |
12 |
$2.00 |
| 90687 |
|
22 |
22 |
$0.00 |
| 90707 |
|
17 |
16 |
$0.00 |
| 90697 |
|
169 |
169 |
$0.00 |